Reproductive-age women with SLE are prone to be impacted by endometriosis. This study analyzes the relationship between HCQ and endometriosis patients with SLE in order to determine whether HCQ is effective for treating the latter.
A new study from China has demonstrated that SLE patients continuously treated with HCQ have a lower risk of developing endometriosis.
A group of 742 women newly diagnosed with lupus and with endometriosis were examined based on age and dosage (high/low) of hydroxychloroquine (HCQ).
For the full study please click here.
